+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up



In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up



Plos Neglected Tropical Diseases 10(7): E0004720




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 058081058

Download citation: RISBibTeXText

PMID: 27416021


Related references

In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis. Plos Neglected Tropical Diseases 8(7): E2999, 2014

Draft Genome Sequences of Leishmania ( Leishmania ) amazonensis , Leishmania ( Leishmania ) mexicana , and Leishmania ( Leishmania ) aethiopica , Potential Etiological Agents of Diffuse Cutaneous Leishmaniasis. Microbiology Resource Announcements 8(20):, 2019

Inefficacy of the association N-methyl glucamine and topical miltefosine in the treatment of experimental cutaneous leishmaniasis by Leishmania (Leishmania) amazonensis. Journal of Venomous Animals and Toxins including Tropical Diseases 13(3): 598-606, 2007

Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment. American Journal of Tropical Medicine and Hygiene 75(6): 1074-1077, 2006

Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis. Journal of Antimicrobial ChemoTherapy 71(5): 1314-1322, 2016

Case report: Transient success using prolonged treatment with miltefosine for a patient with diffuse cutaneous leishmaniasis infected with Leishmania mexicana mexicana. American Journal of Tropical Medicine and Hygiene 88(1): 153-156, 2013

Evaluation of the efficacy of systemic miltefosine associated with photodynamic therapy with liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL/6 mice. Photodiagnosis and Photodynamic Therapy 13: 282-290, 2016

Nipple involvement in diffuse cutaneous leishmaniasis (DCL) produced by Leishmania (L) amazonensis. Revista Da Sociedade Brasileira de Medicina Tropical 28(2): 139, 1995

In vivo Terbinafine inefficacy on cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL/6 mice. Revista Da Sociedade Brasileira de Medicina Tropical 36(4): 531-533, 2003

In situ identification of Leishmania amazonensis associated with diffuse cutaneous leishmaniasis in Bahia, Brazil. Memorias do Instituto Oswaldo Cruz 84(4): 585-586, 1989

Antigenic differences of Leishmania amazonensis isolates causing diffuse cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 84(5): 678-680, 1990

Case Report: Atypical Cutaneous Leishmaniasis in a Patient with Mixed Leishmania guyanensis and Leishmania amazonensis Infection. American Journal of Tropical Medicine and Hygiene 99(5): 1165-1169, 2018

First report of diffuse cutaneous leishmaniasis and Leishmania amazonensis infection in Rio de Janeiro State, Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 101(7): 735-737, 2007

Exposure of phosphatidylserine on Leishmania amazonensis isolates is associated with diffuse cutaneous leishmaniasis and parasite infectivity. Plos one 7(5): E36595, 2012

Co-infection by Leishmania amazonensis and L. infantum/L. chagasi in a case of diffuse cutaneous leishmaniasis in Bolivia. Transactions of the Royal Society of Tropical Medicine and Hygiene 96(5): 529-532, 2002